Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/136331Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Pezzani, R | |
| dc.creator | Salehi, B | |
| dc.creator | Vitalini, S | |
| dc.creator | Iriti, M | |
| dc.creator | Zuñiga, FA | |
| dc.creator | Sharifi-Rad, J | |
| dc.creator | Martorell, M | |
| dc.creator | Martins, N | |
| dc.date.accessioned | 2021-09-20T10:53:10Z | - |
| dc.date.available | 2021-09-20T10:53:10Z | - |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 1010-660X | |
| dc.identifier.uri | https://hdl.handle.net/10216/136331 | - |
| dc.description.abstract | Synergy is a process in which some substances cooperate to reach a combined effect that is greater than the sum of their separate effects. It can be considered a natural “straight” strategy which has evolved by nature to obtain more efficacy at low cost. In this regard, synergistic effects may be observed in the interaction between herbal products and conventional drugs or biochemical compounds. It is important to identify and exploit these interactions since any improvement brought by such kind of process can be advantageously used to treat human disorders. Even in a complex disease such as cancer, positive synergistic plant-drug interactions should be investigated to achieve the best outcomes, including providing a greater benefit to patients or avoiding adverse side effects. This review analyzes and summarizes the current knowledge on the synergistic effects of plant-drug interactions with a focus on anticancer strategies. | |
| dc.description.sponsorship | This work was partially supported by CONICYT PIA/APOYO CCTE AFB170007. Acknowledgments: N. Martins would like to thank the Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project ref. UID/BIM/04293/2013 and “NORTE2020—Programa Operacional Regional do Norte” (NORTE-01-0145-FEDER-000012). | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876/147342/PT | |
| dc.relation.ispartof | Medicina (Lithuania), vol.55(4):110 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Anticancer | |
| dc.subject | Conventional chemotherapeutic agents | |
| dc.subject | Plant derivatives | |
| dc.subject | Plant-drug interaction | |
| dc.subject | Synergistic effects | |
| dc.subject | Synergy | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Antineoplastic Agents / therapeutic use | |
| dc.subject.mesh | Drug Antagonism | |
| dc.subject.mesh | Drug Synergism | |
| dc.subject.mesh | Herb-Drug Interactions | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Mice | |
| dc.subject.mesh | Neoplasms / drug therapy | |
| dc.subject.mesh | Oils, Volatile / therapeutic use | |
| dc.subject.mesh | Phytochemicals / therapeutic use | |
| dc.subject.mesh | Phytotherapy | |
| dc.subject.mesh | Polyphenols / therapeutic use | |
| dc.subject.mesh | Rats | |
| dc.title | Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.3390/medicina55040110 | |
| dc.relation.publisherversion | https://www.mdpi.com/1648-9144/55/4/110 | |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.3390-medicina55040110.pdf | 568.13 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
